can tirzepatide cause heart problems Cardiovascular effects of Tirzepatide and Cardiovascular Outcomes: A

Poisoning reports linked to injectable weight-loss drugs nearly doubled in 2025, with experts warning over online and unsupervised use

3 High Growth GLP-1 Biotech Winners to Buy in July

#Semaglutide #GLP1 #TorrentPharma #IndianPharma #Obesity #PharmaStrategy #Generics #HealthcareInnovation | 16 comments on LinkedIn

Postbiotic Support Dried yeast fermentate from Saccharomyces cerevisiae provides postbiotic components that support gut barrier function and digestive wellness as part of normal physiology

Results Mean weight dropped from 133 to 87 kg by year 2, with %EWL peaking at 68% and declining to 63% by year 5

Analyze Pfizer's $10B acquisition of Metsera and the evolving GLP-1 obesity drug market